Cigna Corp (NYSE: CI) Q4 2020 earnings call dated Feb. 04, 2021. Corporate Participants: Alexis Jones — Lead Principal, Investor Relations David Cordani — President and Chief
Cigna Corp (CI) Q4 2020 Earnings Call
Categories
Health Care
Eylea recovery, COVID antibody cocktail make Regeneron an attractive bet
After last year's mixed performance, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) looks to take advantage of the robust pipeline and the success of
Biogen, Inc. (BIIB) Q4 2020 Earnings Call
Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Mike Hencke — Director, Investor Relations Michel Vounatsos — Chief Executive Officer Alfred
Boston Scientific Corp. (BSX) Q4 2020 Earnings Call
Boston Scientific Corp. (NYSE: BSX) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Susie Lisa — Vice President, Investor Relations Michael F. Mahoney — Chairman
Strong pipeline, M&A synergies to keep Bristol Myers on growth path
Bristol Myers Squibb Company (NYSE: BMY) is thriving on its multi-pronged growth plan, based on strategic acquisitions and the promising pipeline. Recently,
Regeneron Pharmaceuticals, Inc. (REGN) Q4 2020 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Q4 2020 earnings call dated Feb. 05, 2021 Corporate Participants: Justin Holko — Vice President, Investor Relations Leonard S.
Cardinal Health Inc. (CAH) Q2 2021 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q2 2021 earnings call dated Feb. 05, 2021 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike
Cigna Corp (CI) Q4 2020 Earnings Call Transcript
Cigna Corp (NYSE: CI) Q4 2020 earnings call dated Feb. 04, 2021. Corporate Participants: Alexis Jones -- Lead Principal, Investor Relations David Cordani -- President and
Bristol Myers (BMY) stock gains after Q4 results beat Street view
Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company's stock gained in the pre-market session soon after the announcement.
Infographic: Highlights of Merck & Co. (MRK)Q4 2020 earnings report
Merck & Co., Inc. (NYSE: MRK) reported weak earnings and sales for the fourth quarter of 2020. Worldwide sales edged up 5%
Pfizer Inc. (PFE) Q4 2020 Earnings Call
Pfizer Inc. (NYSE: PFE) Q4 2020 earnings call dated Feb. 02, 2021 Corporate Participants: Charles E. Triano — Senior Vice President, Investor Relations Albert Bourla — Chairman
Humana Inc (HUM) Q4 2020 Earnings Call Transcript
Humana Inc (NYSE: HUM) Q4 2020 earnings call dated Feb. 03, 2021 Corporate participants: Amy K. Smith -- Vice President, Investor Relations Bruce D.
AbbVie Inc. (ABBV) Q4 2020 Earnings Call Transcript
AbbVie Inc. (NYSE: ABBV) Q4 2020 earnings call dated Feb. 03, 2021. Corporate Participants: Elizabeth Shea -- Vice President of Investor Relations Richard A.
Biogen, Inc. (BIIB) Q4 2020 Earnings Call Transcript
Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Mike Hencke -- Director, Investor Relations Michel Vounatsos -- Chief Executive Officer
Boston Scientific Corp. (BSX) Q4 2020 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Susie Lisa -- Vice President, Investor Relations Michael F.
AbbVie (ABBV) Earnings: 4Q20 Key Numbers
AbbVie Inc. (NYSE: ABBV) reported fourth quarter 2020 earnings results today. Worldwide net revenues rose 59.2% year-over-year to $13.8 billion on a
Infographic: Key financials of Biogen (BIIB) Q4 2020 earnings report
Biogen (NASDAQ: BIIB) reported fourth-quarter 2020 financial results before the opening bell on Wednesday. The biotechnology giant reported a 22% decline in
CorVel (CRVL) expands scope of services as focus shifts to COVID care
In the pandemic-hit healthcare market, CorVel Corporation (NASDAQ: CRVL) is facing a major uncertainty that is as unsettling as the virus itself.
Pfizer Inc. (PFE) Q4 2020 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q4 2020 earnings call dated Feb. 02, 2021 Corporate Participants: Charles E. Triano -- Senior Vice President, Investor Relations Albert
Pfizer (PFE) Q4 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2020 earnings results today. Revenues increased 12% year-over-year to $11.7 billion. On a GAAP
Infographic: Vertex Pharmaceuticals (VRTX) 4Q20 Earnings Results
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported fourth quarter 2020 earnings results today. Total revenues increased 15% year-over-year to $1.62 billion. GAAP net